![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
Protocol IDs
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Aromatase Inhibitor Clinical Trial
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
0412-14
UO1-GM61373-06, NCT00228956
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
0501-37
NCT00352872
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-Menopausal Women With Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
CFEM345DUS59
NCT00688909
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Using the ContureĀ® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
SENORX-S07-002
NCT00699101
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
20050113
NCT00243685
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
WHC-MRI-GU-2006-097
NCT00397761
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
0120070323
NCT00698971
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Letrozole After Tamoxifen in Treating Women With Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
CAN-NCIC-MA17
CALGB-49805, E-JMA17, EORTC-10983, IBCSG-BIG97-01, NCCTG-JMA17, SWOG-JMA17, JRF-Vor-Int-10, NCCTG-CAN-MA17, SWOG-CAN-MA17, NCT00003140, JMA17, MA17
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy in Treating Women With Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
CALGB-40101
CALGB-40101, NCT00041119
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
IBCSG-2402
BIG-2-02, CALGB-IBCSG-2402, CAN-NCIC-IBCSG-2402, NCCTG-IBCSG-2402, NSABP-IBCSG-2402, SWOG-IBCSG-2402, NABCI-IBCSG-2402, UCLA-0403024-01, EU-20334, IBCSG-24-02, NCT00066690, EUDRACT-2004-000166-13
![](https://webarchive.library.unt.edu/eot2008/20080925060805im_/http://www.cancer.gov/images/spacer.gif)
|
|